RAB6A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.148000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.712000E-01
Normal-vs-Stage2
6.451800E-01
Normal-vs-Stage3
4.086000E-01
Normal-vs-Stage4
3.603000E-01
Stage1-vs-Stage2
5.515600E-01
Stage1-vs-Stage3
3.651800E-01
Stage1-vs-Stage4
2.806600E-01
Stage2-vs-Stage3
1.556630E-01
Stage2-vs-Stage4
3.929600E-01
Stage3-vs-Stage4
1.070810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.369200E-01
Normal-vs-AfricanAmerican
4.269200E-01
Normal-vs-Asian
9.559200E-01
Caucasian-vs-AfricanAmerican
5.026400E-01
Caucasian-vs-Asian
4.615000E-01
AfricanAmerican-vs-Asian
3.006000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.323600E-01
Normal-vs-Female
6.979200E-01
Male-vs-Female
8.673800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.081600E-01
Normal-vs-Age(41-60Yrs)
3.257200E-01
Normal-vs-Age(61-80Yrs)
9.377000E-01
Normal-vs-Age(81-100Yrs)
8.873200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.794400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.325000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.857600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.581400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.761700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.004600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.367000E-01
Normal-vs-Daily Drinker
9.787400E-01
Normal-vs-Weekly Drinker
9.708400E-01
Normal-vs-Occasional Drinker
3.710600E-01
Normal-vs-Social Drinker
6.585600E-01
Non Drinker-vs-Daily Drinker
8.990400E-01
Non Drinker-vs-Weekly Drinker
8.319800E-01
Non Drinker-vs-Occasional Drinker
2.022000E-01
Non Drinker-vs-Social Drinker
5.879800E-01
Daily Drinker-vs-Weekly Drinker
9.129400E-01
Daily Drinker-vs-Occasional Drinker
1.333760E-01
Daily Drinker-vs-Social Drinker
4.778600E-01
Weekly Drinker-vs-Occasional Drinker
1.105830E-01
Weekly Drinker-vs-Social Drinker
4.143200E-01
Occasional Drinker-vs-Social Drinker
4.624400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.084200E-01
Normal-vs-Grade 2
9.697200E-03
Normal-vs-Grade 3
3.385800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.222740E-03
Grade 1-vs-Grade 3
5.899300E-03
Grade 1-vs-Grade 4
1.084200E-01
Grade 2-vs-Grade 3
7.224400E-01
Grade 2-vs-Grade 4
9.697200E-03
Grade 3-vs-Grade 4
3.385800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.911600E-01
Normal-vs-NonDiabetic
7.447400E-01
Diabetic-vs-NonDiabetic
5.589400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.972400E-01
Normal-vs-NoPancreatitis
7.847400E-01
Pancreatitis-vs-NoPancreatitis
6.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.355600E-01
Normal-vs-N1
6.360600E-01
N0-vs-N1
3.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.133000E-01
Normal-vs-TP53-NonMutant
8.559200E-01
TP53-Mutant-vs-TP53-NonMutant
4.20250000000566E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
